Carl Zeiss Meditec (ETR:AFX – Get Rating) has been assigned a €215.00 ($231.18) price target by stock analysts at Hauck and Aufhaeuser in a research note issued to investors on Thursday, Borsen Zeitung reports. Hauck and Aufhaeuser’s price target would suggest a potential upside of 59.02% from the stock’s previous close.
A number of other equities research analysts have also recently weighed in on the company. UBS Group set a €170.00 ($182.80) price target on Carl Zeiss Meditec in a report on Wednesday, March 16th. Deutsche Bank Aktiengesellschaft set a €210.00 ($225.81) price objective on Carl Zeiss Meditec in a research report on Monday, February 14th. HSBC set a €146.00 ($156.99) price objective on Carl Zeiss Meditec in a research report on Monday, February 14th. Finally, Deutsche Bank Rese… set a €210.00 ($225.81) price objective on Carl Zeiss Meditec in a research report on Tuesday.
AFX stock opened at €135.20 ($145.38) on Thursday. The business has a fifty day moving average price of €139.16 and a 200 day moving average price of €157.38. Carl Zeiss Meditec has a fifty-two week low of €118.10 ($126.99) and a fifty-two week high of €202.00 ($217.20). The stock has a market capitalization of $12.09 billion and a price-to-earnings ratio of 53.25. The company has a debt-to-equity ratio of 7.23, a current ratio of 3.58 and a quick ratio of 2.90.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
- Steel Dynamics Scales New Heights On Record Results
- Tesla (NASDAQ: TSLA) Stock Hits Four Figures Once Again
- The Institutions Are Driving Knight-Swift Transportation
- 3 Legendary Low-Beta Stocks Set to Outperform
- Affirm Stock Has Affirmed a Bottom
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.